Abstract:Background: Several studies suggested an important role of the gut microbiota in the pathophysiology of neurological disorders, implying that alteration of the gut microbiota might serve as a treatment strategy. Fecal microbiota transplantation (FMT) is currently the most effective gut microbiota intervention and an accepted treatment for recurrent Clostridioides difficile infections. To evaluate indications of FMT for patients with neurological disorders, we summarized the available literature on FMT. In addition, we provide suggestions for future directions.Methods: In July 2019, five main databases were searched for studies and case descriptions on FMT in neurological disorders in humans or animal models. In addition, the <a href="https://www.ClinicalTrials.gov">ClinicalTrials.gov</a> website was consulted for registered planned and ongoing trials.Results: Of 541 identified studies, 34 were included in the analysis. Clinical trials with FMT have been performed in patients with autism spectrum disorder and showed beneficial effects on neurological symptoms. For multiple sclerosis and Parkinson's disease, several animal studies suggested a positive effect of FMT, supported by some human case reports. For epilepsy, Tourette syndrome, and diabetic neuropathy some studies suggested a beneficial effect of FMT, but evidence was restricted to case reports and limited numbers of animal studies. For stroke, Alzheimer's disease and Guillain-Barré syndrome only studies with animal models were identified. These studies suggested a potential beneficial effect of healthy donor FMT. In contrast, one study with an animal model for stroke showed increased mortality after FMT. For Guillain-Barré only one study was identified. Whether positive findings from animal studies can be confirmed in the treatment of human diseases awaits to be seen. Several trials with FMT as treatment for the above mentioned neurological disorders are planned or ongoing, as well as for amyotrophic lateral sclerosis.Conclusions: Preliminary literature suggests that FMT may be a promising treatment option for several neurological disorders. However, available evidence is still scanty and some contrasting results were observed. A limited number of studies in humans have been performed or are ongoing, while for some disorders only animal experiments have been conducted. Large double-blinded randomized controlled trials are needed to further elucidate the effect of FMT in neurological disorders.

Fecal Microbiota Transplantaion in the treatement of mood disorders : A literature review

Current landscape of fecal microbiota transplantation in treating depression

Gut Microbial Clues to Bipolar Disorder: State‐of‐the‐art Review of Current Findings and Future Directions

Pick fecal microbiota transplantation to enhance therapy for major depressive disorder

Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation

Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review

Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report

[Fecal Microbiota Transplants in the Context of (Child and Adolescent) Psychiatric Disorders]

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain

Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial

Microbiota-Orientated Treatments for Major Depression and Schizophrenia

Fecal Microbiota Transplantation in Neurological Disorders

Clinical Application and Potential of Fecal Microbiota Transplantation

Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review

A detailed review on Fecal Microbiota Transplantation (FMT)

Patient Perceptions of Microbiome-Based Therapies as Novel Treatments for Mood Disorders: A Mixed Methods Study: Perceptions des patients sur les thérapies basées sur le microbiome pour les troubles de l'humeur : une étude à méthodes mixtes

Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases

Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression

Fecal microbiota transplantation in disease therapy

Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety

Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review